chrisvoncsefalvay/vaers-outcomes huggingface dataset:
5 days later of the vaccine on 1/01/2021 on evening I felt like my armpit was ripped raw the next day on 1/2/2021 I had a lump under my left armpit it was very swollen to the point where I couldn't put my hand touching my body then on the next day on my left side on my neck it also got very swollen it went away until 1/6/2021.
08/26/2011 Severe anaphylactic reaction. Patient loss airway with flu vaccine. Loses airway when in certain buildings.
On the 7th of February 2021, I woke up and swung my legs out of bed to get up and I couldn't stand up or walk. So, I stayed in bed for a while, I tried several times to get up and couldn't do it. My daughter came and got me and took me to my primary physician. My physician ordered an MRI. The result was that my spine was filled with arthritis. I was referred to the surgeon who gave me the steroid shots in my back. The surgeon then referred me to physical therapy, and I had two months worth of therapy up through April 2021. It worked and it got me back on my feet. I just had another 8-week session of back physical therapy. It was sort of a short term disability.
Moderna Covid-19 Vaccine, Bivalent 0.25mL, instead of 0.5mL to given adult patients; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of ACCIDENTAL UNDERDOSE (Moderna Covid-19 Vaccine, Bivalent 0.25mL, instead of 0.5mL to given adult patients) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On an unknown date, the patient experienced ACCIDENTAL UNDERDOSE (Moderna Covid-19 Vaccine, Bivalent 0.25mL, instead of 0.5mL to given adult patients) and NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (Moderna Covid-19 Vaccine, Bivalent 0.25mL, instead of 0.5mL to given adult patients) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (Moderna Covid-19 Vaccine, Bivalent 0.25mL, instead of 0.5mL to given adult patients).    No concomitant medication information provided. No treatment information provided.
terrible acid reflux,I just wanted to die it was so bad; She was in so much pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 61 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 18Mar2021 (Lot number: ER2613, Expiration Date: 31Jul2021) at the age of 61 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Diabetes", start date: 2005 (unspecified if ongoing); "she first came down with acid reflux in the 90's, late 90's" (unspecified if ongoing); "She has other sickness" (unspecified if ongoing). The patient took concomitant medications. Past drug history included: Metformin for Diabetes, reaction(s): "Acid reflux"; Metformin for Diabetes, reaction(s): "Gastritis". The following information was reported: GASTROOESOPHAGEAL REFLUX DISEASE (non-serious) with onset 2021, outcome "recovered with sequelae" (2021), described as "terrible acid reflux,I just wanted to die it was so bad"; PAIN (non-serious) with onset 2021, outcome "recovered with sequelae" (2021), described as "She was in so much pain". The events "terrible acid reflux,i just wanted to die it was so bad" and "she was in so much pain" were evaluated at the physician office visit and emergency room visit.  Additional Context: She had the vaccine, first injection of Pfizer, on 18Mar2021. After she had the shot she got like a bad case of acid reflux. It was so severe. She was in so much pain. It got better then she started with another round of it. She is trying to cover herself from COVID19. At first caller said she wasn't going to do it and then they started experiencing things. She told her mom they needed to get it. Her mom got the Johnson and Johnson COVID vaccine. Her mom had stuff going on and initially she was fine. Caller's son had Pfizer and he is fine. Once caller made her mind up, she took it. Caller has other stuff going on with her body. She has other sickness and she was a candidate to take it, so she took it.   No follow-up attempts are possible. No further information is expected.
This is a spontaneous report from a contactable nurse. A 18-year-old female patient received the second dose of TRUMENBA, (lot number M13066, expiration date 01Sep2016) at 0.5 ml single dose intramuscular in the left arm on 04Jan2016 at 19:45 as recommended for age group. Medical history included depression and anxiety started on 19May2014 and ongoing, migraine headache from Dec2013, acne from Dec2014. Concomitant medication included ongoing ZOLOFT at 37.5 mg once daily form Nov2014 and ongoing for depression, anxiety. On 04Jan2016 by 11 pm the patient she was complaining of an incredibly bad pressure headache, shivering, uncontrollable shaking, burning at injection site, and very uncomfortable. At midnight, the patient had vomited 4 times and had no fever at that point per the mother. The mom maybe thought the patient had a low grade temperature the following morning. No specific tests and/or treatment were required. The AEs did not require and emergency room or physician visit. The patient recovered on 05Jan2016. The patient was able to go to school on 05Jan2016. The pharmacist stated that the patient provided to him/her information regarding the reported adverse events with the use of the suspect. The pharmacist considered there was a reasonable possibility that the event is related to suspect product. The pharmacist was not willing to be contacted again by Pfizer on the reported adverse events. Follow-up attempts completed. No further information expected. Follow-up (28Jun2016): New information reported form a contactable pharmacist on behalf of physician included: Medical History, concomitant medication therapy date/indication; reporter informed regarding the adverse events; reporter event causality assessment; reporter further contactability.
12/28-12/29: arm/injection site soreness, then subside; 1/3-1/4-itchiness, increased pain/tenderness at injection site; 1/5-injection site tender/red/sore/swelling with increased area (used IB profen/topical cortisone); 1/6-same as 1/5 but milder and less redness; 1/7-mild tenderness with most other symptoms resolved
Heart rate from 105 to 120; chills felt like flu; oxygen turned up from 2L to 4L went; chills felt like flu; This is a spontaneous report from a contactable consumer (reporting for himself) from the Pfizer sponsored program.  A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization.  Medical history included: chronic obstructive pulmonary disease (COPD) and lung function 37%. The patients concomitant medications were not reported.  On an unspecified date, the patient experienced heart rate from 105 to 120, chills felt like flu and oxygen turned up from 2 liters (L) to 4 L went.  About 3 and a 1/2 days after the vaccination, the patients heart rate was from 105 to 120 and chills felt like flu no fever, so his oxygen was turned up from 2L to 4L.  He went through that for six hours and decided it might be COVID.  The patient took 12mg of Ivermectin (MANUFACTURER UNKNOWN), 10 mg of melatonin (MANUFACTURER UNKNOWN) and alprazolam (XANAX) went to bed and was good 12 hours later. The patient also reported that budesonide formoterol fumarate (SYMBICORT) caused him to be tachy.  The patient underwent lab tests and procedures which included heart rate: 105 to 120 on an unspecified date. Therapeutic measures were taken as a result of the events as aforementioned.  The outcome of the events was unknown.    The batch/lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.
Headaches  4 days, fatigue, myalgias Shingles like rash.  Rash in left arm, shoulder and back concomitant w/pain and itchiness of shoulder
Patient started feeling muscle quivering around 3 pm, the whole body shaking, problems breathing, nausea for 5 to 6 hours. Patient was laying under blankets, could not walk. After 5 -6 hours breathing has improved. Patient is still feeling fatigued at 10:15 am 10/27/2022.
Day 1 (day after receiving vaccine - 10/18): Severe muscle aches; headache; chills; nausea Day 2 (following day 10/19):  Hot flashes
Pt received flu shot. Bled a bit (but pt on blood thinner). Noticed area appeared to swell almost immediately after vaccination. Pt didn't report any issues (RPh noticed swelling). No s/sx of SOB or altered consciousness. Spoke to pt's PCP who wanted pt to get BENADRYL (which was given to him) & proceed to ER. Pt did not want 911 called or ambulance to take him to ER. Swelling of area a nickel to quarter sized and firm to touch.
A vaccine dose was administered to a homebound patient. The dose was prepared and stored in a portable cooler with a data logger by the Health Department. Paramedics administering the dose did not recognize the cooler temperature was below the temperature storage range of the vaccine. The vaccine was administered without adverse effects to the patient during the 30 minute period the patient was observed.
Shingles in my left eye; This case was reported by a consumer and described the occurrence of ophthalmic herpes zoster in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 17th May 2021 11:30, the patient received Shingrix. On 18th May 2021, 1 days after receiving Shingrix, the patient experienced ophthalmic herpes zoster (serious criteria GSK medically significant). On an unknown date, the outcome of the ophthalmic herpes zoster was unknown.   It was unknown if the reporter considered the ophthalmic herpes zoster to be related to Shingrix.  Additional details were provided as follows:  The age at vaccination was not reported.  The age group was not reported but was captured as adult as per vaccine indication. The patient received Shingrix vaccine and developed Shingles in left eye.
This spontaneous report as received from a pharmacist refers to a 58 years old female patient with allergy to sulfa, amoxicillin and penicillin and osteoarthritis. The patient's medical history included shingles. The patient was vaccinated with liveZOSTAVAX (lot # reported as was H018188, expiration date 04-JAN-2014, dose was unknown) subcutaneously on 09-JAN-2013. No other co-suspects were reported. No concomitant medications were reported. The pharmacist noted that "on 10-JAN-2013 the patient a one-inch-by-one-inch size redness around the injection site which was warm, swollen, and hard, but no blistering." The present patient status was not recovered. No treatment was given for adverse event. No lab diagnosis studies performed. The patient presented at the pharmacy to the reporting pharmacist for medical attention. The relatedness of event was unknown for live ZOSTAVAX. This is one of several reports received from the same source. Additional information is not expected.
Severe Gastric Issues - I had the issue for a year in a mild format. After first dose I got really bad but I tried to manage that; Severe Gastric Issues - I had the issue for a year in a mild format. After first dose I got really bad but I tried to manage that; This is a spontaneous report from a contactable consumer or other non hcp.  A 34-year-old non-pregnant female patient received bnt162b2 (COMIRNATY, formulation: solution for injection, lot number: EL6203 expiration date were not reported) via an unspecified route of administration, administered at arm right on 26Feb2021 19:00 (at the age of 34-year-old) as dose 1, single for COVID-19 immunization. The patient, medical history included gastric issues from an unknown date and unknown if ongoing (Severe Gastric Issues - I had the issue for a year in a mild format). Concomitant medications included pantoprazole, simeticone (PHAZYME), amitriptyline, vitamin D taken for an unspecified indication, start and stop date were not reported. No pregnancy at the time of vaccination. Facility where the most recent COVID-19 vaccine was administered: Workplace clinic. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Allergies to medications, food, or other products: No. Location of injection information is available for all vaccines received on the same date. On 20Mar2021, the patient experienced severe gastric issues - she had the issue for a year in a mild format. After first dose she got really bad but she tried to manage that and she thought that was related to the old issue that she had (condition aggravated). No treatment was received for the adverse event. Yesterday, she got the second dose and today she was in pain and she felt burn on her esophagus. The outcome of the events was not recovered.  No follow-up attempts are needed. No further information expected.
I had a Moderna booster and 8 days later broke out in hives all over my body. The itching was the worst at night and started on my palms, then torso. The hives were hot to the touch and any slight pressure or scratching triggers them. I went to a dermatologist who recommended taking up to 3 oral antihistamines a day. I have been taking 2 zurtec a day and 1 benadryl at night. After 2 weeks, I was less itchy thankfully, but now over a month into it, I still wake up and go to sleep with the marks triggered by slight pressure or scratching. I am hoping this subsides soon because I feel like I have hit a plateau with the oral antihistamines. I have also adjusted my diet to avoid high histamine foods.
pt says he when he woke up his right arm pit was swollen and it is still like this 3 days later.  He is waiting for his PCP to call him back.
Symptoms of covid and Caught COVID after first dose and tested positive; Congestion; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Symptoms of covid and Caught COVID after first dose and tested positive) and NASAL CONGESTION (Congestion) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced COVID-19 (Symptoms of covid and Caught COVID after first dose and tested positive) and NASAL CONGESTION (Congestion). At the time of the report, COVID-19 (Symptoms of covid and Caught COVID after first dose and tested positive) and NASAL CONGESTION (Congestion) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Mar-2021, SARS-CoV-2 test positive: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were provided by the reporter.
Arm never stopped hurting after taking the injection. It has become a severe pain to his elbow and he can't raise it no higher than his chest.
No additional AE; temperature excursion in which PROQUAD and V ARlV AX may have been administered to patient(s).; This spontaneous report as received from a nurse and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 15-APR-2021, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) lot # T024284, expiration date: 15-JUL-2022, dose 1 (formulation, strength, exact dose, frequency, route of administration were not reported) for prophylaxis. On an unknown date, the dose of the vaccine was exposed to temperature excursion at 17.32 Fahrenheit degrees (F) for 1 hour 22 minutes. There was no previous temperature excursion reported. The call was due to digital data logger. No additional adverse event was reported.
Visual aura; Splitting migraine; Migraine that prevented from sleeping; Nauseous; Vaccinated arm very painful; Dizzy; This is a spontaneous report from a contactable consumer, the patient. A 19-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration on 12May2021 (at the age of 19-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID -19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. On an unknown date in May2021, about 11 hours after the first dose, the patient had a visual aura that lasted over 1.5 hours and a splitting migraine that prevented her from sleeping. She was not prone to nausea but was very nauseous right now (at the time of this report). Her vaccinated arm was very painful and she was dizzy. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events visual aura, splitting migraine, migraine that prevented from sleeping, nauseous, vaccinated arm very painful, dizzy were recovering at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Pressure in chest, never experienced before or since, exactly in the area of the heart, that increased with physical activity (walking), and lasted 3 weeks, even after treatment with colchicine.
On 11/30, pt began to develop a rapid heart rate. Mother took pt to ER. Mother reported a heart rate of 206. While in the ER, heart rate was 187 at 1720. Labs were ordered and an EKG was done. At 1738, pt was converted to sinus tach with a heart rate of 130 after preforming a modified Valsalva maneuver by having pt try to blow the plunger out of a 10cc syringe while laying on he back. Had immediate improvement of symptoms. At 1836, pt's heart rate was 126 with a blood pressure at 110/80. Pt was discharged after a consultation with pediatric cardiologist.  Pt had a follow up in office with her pcp on 12/02/21 and goes to Hospital on 12/09/21 for a follow up with a cardiologist.
Tachycardia; Difficulty breathing while Lying down; This is a spontaneous report from a contactable consumer Other HCP nurse (patient). A 33-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: Ewo0183), via an unspecified route of administration in Arm Left on 17May2021 16:00 (age at the time of vaccination 33-years-old), single dose for COVID-19 immunization. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: Ew0162), via an unspecified route of administration on 18Apr2021 03:00 PM (age at the time of vaccination 33-years-old), single dose for COVID-19 immunization. The patient's medical history and concomitant medication were not reported. The patient had no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive within 2 weeks of vaccination. On 18May2021 22:00 the patient experienced Tachycardia, and Difficulty breathing while Lying down. On 25Jan2021, the patient underwent lab tests and procedures which included Nasal Swab, SARS-CoV-2 test: Pending. Patient received Tylenol treatment for the adverse event. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events was recovered on an unspecified date 2021.  Follow-Up (15Jul2021): Follow-up attempts are completed. No further information is expected.  Follow-up (23Jul2021): Follow-up attempts are completed. No further information is expected.
Mother describes that on day of presentation, 1 hour after feed, had several episodes in which he stopped breathing, stiffening of whole body, drooling, rolling of eyes and decreased response to stimuli lasting 1-2 minutes and recurred every 15-20 minutes several times. He would resume breathing in between episodes.
Saturday after the injection, I had no symptoms. Sunday I woke up with a headache and a sore throat, didn?t feel well. That night I had chills, and temperature of 100.4. Monday morning I couldn?t get out of bed, too much pain to lift myself Up. When I did I had trouble lowering myself and rising up from the toilet. Went in the living room tried to sit, very painful, also pain in the front of my thighs. I called my doctor and scheduled a telehealth meet for 4/29/21, but I went to the wellness clinic to see dr., I saw  a nurse practitioner. She told me I had Sciatica possibly reacted by the Moderna injection. My dr. agreed. The nurse practitioner put me on some muscle relaxers.I don?t know the outcome yet or when I can go back to work. It could be disabling, but hopefully go away.
Pt lost consciousness in waiting room unwitnessed by staff. Transferred to the ED. Seizure activity noted.
Later on the afternoon my left arm felt sore it was hurting. At 3am I woke up with bad chills & a really bad headache. I've never had a fever and I had one of 99.9 I felt very sick & I went to the ER they gave me medicine for my headache. They told me it was the side effects of the vaccine.
I developed a sun allergy - it started out as itchy red rash and developed to Hives. I contacted Dermatologist (a friend who lives out of  the country - informal doctor visit)- He prescribed Allegra 10 days; Hydrocortisone cream and some Aloe Vera gel. It took about 5-6 days, then they subsided. But even now when I go back into the sun, I still have the symptoms reappear and I still get itchy. They aren't as bad as they were the first time but I still get itchy and the red rash appears.
Dose was given 21 days following initial immunization on 08/06/2021 rather than 28 days as recommended.
Lip swelling near filler site that lasted 3 days.; This spontaneous case was reported by a non-health professional and describes the occurrence of LIP SWELLING (Lip swelling near filler site that lasted 3 days.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 23-Mar-2021, the patient experienced LIP SWELLING (Lip swelling near filler site that lasted 3 days.). At the time of the report, LIP SWELLING (Lip swelling near filler site that lasted 3 days.) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Reporter did not allow further contact
By patient reported only not seen at time of event.Came 2 weeks later to be seen. Reported and had iphone pictures of rash that developed after initial pruritus face distal forearm and distal legs.2days later slight swelling of eye and bridge of nose.s/s restored in one - one and a half weeks. Only a slight fine erythrema on the distal forearms on 4/23/2019